Telomir Pharmaceuticals I... (TELO)
NASDAQ: TELO
· Real-Time Price · USD
1.34
-0.05 (-3.60%)
At close: Sep 29, 2025, 3:59 PM
1.36
1.49%
After-hours: Sep 29, 2025, 07:42 PM EDT
-3.60% (1D)
| Bid | 1.34 |
| Market Cap | 43.95M |
| Revenue (ttm) | 18.79M |
| Net Income (ttm) | -16.14M |
| EPS (ttm) | -0.54 |
| PE Ratio (ttm) | -2.48 |
| Forward PE | -4.89 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 1.38 |
| Volume | 262,070 |
| Avg. Volume (20D) | 4,603,347 |
| Open | 1.39 |
| Previous Close | 1.39 |
| Day's Range | 1.34 - 1.41 |
| 52-Week Range | 1.12 - 7.08 |
| Beta | -0.73 |
| Ex-Dividend Date | n/a |
About TELO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol TELO
Website n/a
3 weeks ago
+10.57%
Telomir Pharmaceuticals shares are trading higher ...
Unlock content with
Pro Subscription
1 month ago
+0%
TELO stock has given up its prior gain. Telomir Pharmaceuticals shares were trading higher after highlighting in vitro results for Telomir-1.
